Daniel James George, MD

Professor of Medicine
Professor in Surgery
Member of the Duke Cancer Institute
Campus mail Duke Box 103861, Durham, NC 27710
Phone (919) 668-4615
Email address daniel.george@duke.edu

Education and Training

  • Fellow in Medical Oncology, Medicine, Johns Hopkins University, 1995 - 1998
  • Medical Resident, Medicine, Johns Hopkins University, 1992 - 1995
  • M.D., Duke University, 1992

Grants

Publications

George, Daniel J. “Treatment options for patients with prostate cancer who develop metastatic disease after hormonal therapy.” Clin Adv Hematol Oncol 17, no. 7 (July 2019): 382–85.

PMID
31449503
Scholars@Duke

Pal, Sumanta, Jun Gong, Shivani K. Mhatre, Shih-Wen Lin, Andy Surinach, Sarika Ogale, Rini Vohra, Herschel Wallen, and Daniel George. “Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database.” Bmc Cancer 19, no. 1 (June 7, 2019): 548. https://doi.org/10.1186/s12885-019-5716-z.

PMID
31174493
Full Text

Labriola, Matthew K., Kristen A. Batich, Jason Zhu, Megan A. McNamara, Michael R. Harrison, Andrew J. Armstrong, Daniel J. George, and Tian Zhang. “Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma.” Clin Genitourin Cancer 17, no. 3 (June 2019): e513–21. https://doi.org/10.1016/j.clgc.2019.01.017.

PMID
30858035
Full Text

Heath, Elisabeth I., David M. Nanus, Susan Slovin, Chuck Strand, Celestia Higano, Virgil H. Simons, Crawford Johnson, et al. “Prostate Cancer National Summit's Call to Action.” Clin Genitourin Cancer 17, no. 3 (June 2019): 161–68. https://doi.org/10.1016/j.clgc.2019.04.002.

PMID
31085057
Full Text

Robinson, Timothy J., Jennifer A. Freedman, Muthana Al Abo, April E. Deveaux, Bonnie LaCroix, Brendon M. Patierno, Daniel J. George, and Steven R. Patierno. “Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities.” Clin Cancer Res 25, no. 10 (May 15, 2019): 2963–68. https://doi.org/10.1158/1078-0432.CCR-18-2445.

PMID
30755441
Full Text

Armstrong, Andrew J., Susan Halabi, Jun Luo, David M. Nanus, Paraskevi Giannakakou, Russell Z. Szmulewitz, Daniel C. Danila, et al. “Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study.” J Clin Oncol 37, no. 13 (May 1, 2019): 1120–29. https://doi.org/10.1200/JCO.18.01731.

PMID
30865549
Full Text

George, D. J. “Outcomes.” Clinical Advances in Hematology and Oncology 17, no. 5 (May 1, 2019): 258.

Scholars@Duke

Den, Robert B., Daniel George, Christopher Pieczonka, and Megan McNamara. “Ra-223 Treatment for Bone Metastases in Castrate-Resistant Prostate Cancer: Practical Management Issues for Patient Selection.” Am J Clin Oncol 42, no. 4 (April 2019): 399–406. https://doi.org/10.1097/COC.0000000000000528.

PMID
30844849
Full Text

George, Daniel J. “Highlights in Advanced Prostate Cancer from the 2019 ASCO Genitourinary Cancers Symposium: Commentary.” Clin Adv Hematol Oncol 17 Suppl 8, no. 4 (April 2019): 17–19.

PMID
32692735
Scholars@Duke

George, D. J. “Talk to me.” Clinical Advances in Hematology and Oncology 17, no. 3 (March 1, 2019): 142.

Scholars@Duke

Pages